Defining Efficacy Without Proof Of Benefit: FDA Panel To Assess Otsuka’s Samska
This article was originally published in The Pink Sheet Daily
Executive Summary
Cardio-Renal Advisory Committee meets June 25 to review tolvaptan’s effect on serum sodium in hyponatremia.